Mylan Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report
ICD Research's Mylan Inc. : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major products and services, swot analysis, business description, company history, financial analysis, recent developments, key employees, company locations and subsidiaries, employee biographies as well as competitive benchmarking data.
This report is a crucial resource for industry executives and anyone looking to access key information about Mylan Inc.
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Examines and identifies key information and issues about Mylan Inc. for business intelligence requirements.
Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
Provides data on company financial performance and competitive benchmarking.
The profile also contains information on business operations, company history, major products and services, key employees, locations and subsidiaries.
Reasons To Buy
Quickly enhance your understanding of Mylan Inc.
Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
Increase business/sales activities by understanding your competitors’ businesses better.
Recognize potential partnerships and suppliers.
Mylan Inc. (Mylan) specializes in the development, licensing, production, commercialization, and distribution of generic and branded generic pharmaceutical products and active pharmaceutical ingredients (API). Mylan markets over 1,100 products to consumers in more than 150 countries and territories across the world. The company offers an extensive range of dosage forms and delivery systems, including topicals, oral solids, semi-solids, liquids, and others. It also produces high potency formulations, steriles, injectables, transdermal patches, controlled release and respiratory delivery products. The company primarily operates in the US, Canada, Europe, the Middle East, Africa, Australia, India, Japan and New Zealand. Mylan is headquartered in Canonsburg, Pennsylvania, the US.